In utero intravascular transfusion for treating fetal hemolytic disease. 1991

S A Laifer, and J A Kuller, and L M Hill
Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pennsylvania 15213.

Technologic advances in ultrasound have led to the ability to access the fetal circulation in utero. Precise evaluation and accurate treatment of fetal hemolytic disease is now possible. This technique of in utero intravascular transfusion has several advantages. It uses a closed system that reduces the risk of infection and air embolus. The proximal extension tubing minimizes manipulation of the hub of the needle, which may lead to dislodgement of the needle, and permits a sampling port with minimal dead space between it and the fetal circulation. The HemoCue hemoglobinometer allows for rapid assessment of the concentration of fetal hemoglobin and, therefore, a shorter interval of time in which the needle is in the umbilical cord. This reduces the risks of trauma to the umbilical cord.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D001805 Blood Transfusion, Intrauterine In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL). Fetal Transfusion,Intrauterine Transfusion,Blood Transfusions, Intrauterine,Fetal Transfusions,Intrauterine Blood Transfusion,Intrauterine Blood Transfusions,Intrauterine Transfusions,Transfusion, Fetal,Transfusion, Intrauterine,Transfusion, Intrauterine Blood,Transfusions, Fetal,Transfusions, Intrauterine,Transfusions, Intrauterine Blood
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S A Laifer, and J A Kuller, and L M Hill
January 1966, Gynecologie et obstetrique,
S A Laifer, and J A Kuller, and L M Hill
January 1991, Revista chilena de obstetricia y ginecologia,
S A Laifer, and J A Kuller, and L M Hill
May 1969, Lyon medical,
S A Laifer, and J A Kuller, and L M Hill
July 1990, American journal of perinatology,
S A Laifer, and J A Kuller, and L M Hill
January 1967, Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,
S A Laifer, and J A Kuller, and L M Hill
January 1965, Gynecologie et obstetrique,
S A Laifer, and J A Kuller, and L M Hill
March 1986, American journal of obstetrics and gynecology,
S A Laifer, and J A Kuller, and L M Hill
January 1966, Gynecologie et obstetrique,
S A Laifer, and J A Kuller, and L M Hill
January 1998, The Journal of maternal-fetal medicine,
S A Laifer, and J A Kuller, and L M Hill
March 1988, American journal of obstetrics and gynecology,
Copied contents to your clipboard!